A Supersaturated Oxygen Emulsion for Wound Care and Skin Rejuvenation

March 2020 | Volume 19 | Issue 3 | Original Article | 250 | Copyright © March 2020


Published online February 3, 2020

doi:10.36849/JDD.2020.4728

Michael H. Gold MD,a Mark S. Nestor MD PhDb

aGold Skin Care Center, Nashville, TN; Tennessee Clinical Research Center, Nashville, TN; Vanderbilt University School of Nursing, Nashville, TN; Meharry Medical College, School of Medicine, Nashville, TN bCenter for Clinical and Cosmetic Research, Aventura, FL; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery Department of Surgery, Division of Plastic Surgery University of Miami Miller School of Medicine, Miami, FL

Abstract
Although oxygen is essential for proper wound healing, wounds are often hypoxic with diminished oxygen delivery to the healing tissue. Since oxygenation of the outer layers of skin is almost exclusively provided by the atmosphere, increasing the presence of external oxygen enhances the healing process. Hyperbaric oxygen therapy is beneficial for treating nonhealing wounds, such as diabetic ulcers, and has been used to speed post-treatment recovery following aesthetic procedures; however, it is not suitable for home use. Recently, perfluorocarbon emulsions have been developed that can absorb large amount of oxygen. Preparations containing 2% of these compounds can absorb up to seven-times more oxygen than water at 37°C. A topical perfluorocarbon emulsion consisting of perfluorodecalin, water, plant derived emulsifiers, and a preservative, has been developed for use in dermatology (Cutagenix™ & Cutavive™ Professional Skin Care Emulsion; Cutagenesis, Niwot, CO). Designed to be applied 2 to 4 times daily following skin rejuvenation procedures, this topical oxygen emulsion reduces the incidence of post-procedure complications. The application of a topical emulsion is well-suited for patient application to enhance recovery following energy-based aesthetic procedures.

J Drugs Dermatol. 2020;19(3): doi:10.36849/JDD.2020.4728

BACKGROUND

Wound healing is a complex process during which the skin and underlying tissues are repaired through several well-defined phases.1 One of the key factors in the healing process is tissue oxygenation, especially during the early phases of healing.2 Although initial hypoxia is required to initiate the healing process,3 increased oxygen tension becomes necessary to stimulate phagocytosis, provide mitochondrial energy, enhance angiogenesis, increase keratinocyte differentiation, migration, and re-epithelialization, enhance fibroblast proliferation and collagen synthesis, and promote wound contraction. Oxygen is also essential for producing superoxide by polymorphonuclear leukocytes which is necessary for destroying invading pathogens.2-5

Unfortunately, wounds are typically hypoxic with diminished oxygen delivery to the healing tissue.6 It has been estimated that wounds require a tissue oxygen tension ≥20 mm Hg to heal while non-healing wounds have transcutaneous oxygen pressure (tcpO2) as low as 5 mm Hg.7 In one study, tcpO2 ≥30 mm was a predicter of healing success.8 The tcpO2 is especially worrisome for wounds associated with peripheral arterial occlusive disease and diabetic foot ulcers.9 Consequently, the use of occlusive dressings can increase the oxygen deficit and further diminish wound healing.10 Since oxygenation of the outer layers of skin to a depth of 250 to 400 μM is almost exclusively provided by the atmosphere with little coming from circulating blood,11 increasing the presence of external oxygen will enhance the healing process.

Hyperbaric Oxygen
Hyperbaric oxygen therapy (HBOT) refers to the administration of 100% oxygen at ≥1.4 atmosphere within a pressurized chamber.12 During HBOT, tissue oxygen levels of 200 to 400 mm Hg can be achieved.13

HBOT has been shown to upregulate the production of vascular endothelial growth factor (VEGF), variants of platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF) partially through nitric oxide modulation. VEGF and PDGF are responsible for stimulating capillary budding and wound granulation by altering signaling pathways leading to cell proliferation and migration. FGF plays a similar role in angiogenesis, but also induces neural development, keratinocyte organization, and fibroblast proliferation leading to wound granulation and epithelialization.14

HBOT can also enhance the antibacterial effects of oxygen at wound sites. As neutrophils and macrophages enter these environments to kill bacteria and remove necrotic material, they require large amounts of oxygen which is used to create hy-